Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Long-Term Deferred Tax (2021 - 2026)

Zymeworks (ZYME) posted Long-Term Deferred Tax of $4.7 million for Q1 2026, little changed sequentially from $4.7 million in Q4 2025, and down 2.93% YoY from $4.8 million in Q1 2025.

Analysis

Zymeworks (ZYME) Long-Term Deferred Tax (2021 - 2026) Analysis & Trends

Zymeworks has reported Long-Term Deferred Tax for 6 years, with the latest figure at $4.7 million in Q1 2026.

  • Quarterly Long-Term Deferred Tax fell 2.93% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (down 2.93% YoY) and the FY2025 annual result came in at $4.7 million, up 7.34% from the prior year.
  • Long-Term Deferred Tax steadied at $4.7 million in Q1 2026 per ZYME's latest filing, from $4.7 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $4.9 million in Q3 2025 and troughed at $1.3 million in Q3 2023.
  • A 5-year average of $3.5 million and a median of $3.9 million in 2024 frame the typical range for Long-Term Deferred Tax.
  • The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax sank 56.57% in 2023, then jumped 219.85% in 2024.
  • Over 5 years, Long-Term Deferred Tax stood at $1.3 million in 2022, then jumped by 168.77% to $3.6 million in 2023, then climbed by 21.3% to $4.4 million in 2024, then increased by 7.34% to $4.7 million in 2025, then changed by 0.0% to $4.7 million in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $4.7 million, $4.7 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zymeworks 2.13 Bn 1.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.35 Mn
Mar 31, 2026 4.71 Mn
Dec 31, 2025 4.71 Mn
Sep 30, 2025 4.86 Mn
Jun 30, 2025 4.77 Mn
Mar 31, 2025 4.85 Mn
Dec 31, 2024 4.39 Mn
Sep 30, 2024 4.21 Mn
Jun 30, 2024 3.95 Mn
Mar 31, 2024 3.70 Mn
Dec 31, 2023 3.62 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.36 Mn
Mar 31, 2023 1.41 Mn
Dec 31, 2022 1.35 Mn
Sep 30, 2022 3.03 Mn
Dec 31, 2021 3.07 Mn